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Abstract
Summary A single injection of the cyclooxygenase-2 (COX-2)
selective inhibitor NS-398 reduces bone’s osteogenic response
to a single period of mechanical loading in female rats, while
women taking COX-2 selective inhibitors do not have lower
bone mass. We show that daily NS-398 injection does not
influence bone gain from repeated loading in female mice.
Introduction Prostaglandins are mediators of bone cells’
early response to mechanical stimulation. COX-2 expression
is up-regulated by exposure of these cells to mechanical
strain or fluid flow, and the osteogenic response to a
single loading period is reduced by COX-2 inhibition. This
study determined, in female mice in vivo, the effect of
longer term COX-2 inhibition on adaptive (re)modelling
of cortical and trabecular bone in response to repeated
loading.
Methods Nineteen-week-old female C57BL/6 mice were
injected with vehicle or NS-398 (5 mg/kg/day) 5 days a
week for 2 weeks. On three alternate days each week,
the right tibiae/fibulae were axially loaded [40 cycles
(7 min)/day] three hours after injection. Left limbs acted
as internal controls. Changes in three-dimensional bone
architecture were analysed by high-resolution micro-
computed tomography.
Results In control limbs NS-398 was associated with reduced
trabecular number but had no influence on cortical bone. In
loaded limbs trabecular thickness and cortical periosteally
enclosed volume increased. NS-398 showed no effect on this
response.
Conclusion Pharmacological inhibition of COX-2 by NS-
398 does not affect trabecular or cortical bone’s response to
repeated mechanical loading in female mice and thus would
not be expected to impair the functional adaptation of bone
to physical activity in women.
Keywords Bone architecture . Cyclooxygenase-2 selective
inhibitor . Exercise . Female .Mechanical loading
Introduction
Mechanical loading is the principal functional determinant
of bone mass and architecture [1–3], and numerous studies
have shown that prostaglandin signalling plays a key role in
mechanotransduction, with cyclooxygenase-2 (COX-2) ex-
pression being rapidly up-regulated in both osteoblasts and
osteocytes following exposure to fluid flow or mechanical
strain in vitro [4–6]. Blocking prostaglandin production
with indomethacin in experimental animals in vivo has
repeatedly been shown to impair the osteogenic response
to a single period of mechanical loading in cortical and
trabecular bone [7–9]. Two studies in female rats have also
shown that a single injection of the COX-2 selective inhib-
itor NS-398, 3 h prior to a single period of mechanical
loading, reduces the osteogenic response in the cortex [9,
10]. However, the effect of more sustained COX-2 selective
inhibition on the adaptive response to mechanical loading in
cortical bone remains less clear and is unknown in trabecu-
lar bone. In the cortex, the osteogenic response to two
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episodes of mechanical loading in genetically modified fe-
male mice lacking COX-2 was not impaired [11]. This could
be due to compensation for the complete absence of COX-2
over the animals’ life time, a response which is less relevant to
the clinical situation using COX-2 selective inhibitors if sim-
ilar compensation occurs over the comparatively shorter term.
This issue is important to resolve, especially in women
who have a higher risk of fragility fractures associated
with osteoporosis than men, because non-steroidal anti-
inflammatory drugs (NSAIDs), including COX-2 selec-
tive inhibitors, are widely prescribed and a decrease in
the skeletal response to physical activity would result in
bone loss. Interestingly, a recent randomized controlled
trial [12] did not find a suppressive effect of ibuprofen,
a nonselective COX inhibitor, on hip areal bone mineral
density (BMD) in premenopausal women who performed
weight-bearing exercise for 9 months. Consistent with this
finding, among the users of COX-2 selective inhibitors, hip
areal BMD was normal in postmenopausal women using
oestrogen replacement therapy and higher in those not using
oestrogen replacement therapy [13]. These clinical data ap-
pear to imply that functional adaptation of bone to daily loads
is not inhibited by COX-2 selective inhibitors in women.
In the present study, we assessed whether NS-398 affects
bone’s response to repeated periods of mechanical loading
in female mice using the well-characterized non-invasive
tibia/fibula axial loading model [14–16]. This model allows
examination of the effect of local mechanical stimulation,
distinct from that of exercise, in both trabecular and cortical
bone compartments. To our knowledge, this is the first study
investigating the effects of a COX-2 selective inhibitor on
trabecular and cortical bone’s adaptive response to repeated
periods of mechanical loading.
Materials and methods
Experimental design
The experiment was conducted in July–August 2009 at the
Royal Veterinary College (London, UK), with the approval
of the relevant ethical committees. Nineteen-week-old
female C57BL/6 mice (Charles River Laboratories, Inc.,
Margate, UK) were divided into two body weight-matched
groups (n08 in each group) and treated with subcutaneous
injections of vehicle [dimethyl sulphoxide (2.5 ml/kg):
Sigma Chemical Co., St. Louis, Missouri, USA] or NS-
398 (Tocris Cookson Inc., Ellisville, Missouri, USA) at a dose
of 5 mg/kg/day for 2 weeks (days 1–5 and 8–12). During this
period, the right tibiae/fibulae were subjected to external
mechanical loading [14–16] 3 h after injection on three alter-
nate days per week (see the “External mechanical loading”
section for details). We selected to use NS-398, rather than
clinically available COX-2 selective inhibitors, to be able to
compare the present data with those using a single injection of
NS-398 and a single period of mechanical loading [9, 10], and
thus, the dose and timing of injection were determined based
on these previous studies [9, 10]. The left tibiae/fibulae were
used as internal controls, as validated in the present model
[16] and confirmed by others in the rat ulna axial loading
model [17], and normal activity within the cages was allowed
between external loading periods. On day 15, animals were
euthanised and their left control and right loaded tibiae/fibulae
collected for analysis of three-dimensional bone architecture.
In the present study, ovariectomy was not performed because
oestrogen withdrawal could modify the effects of COX-2
selective inhibitors on bone [13].
External mechanical loading
The apparatus (model HC10; Zwick Testing Machines Ltd.,
Leominster, UK) and protocol for non-invasively loading
the mouse tibia/fibula have been reported previously
[14–16]. The tibia/fibula was held in place by a low level
of continuous static preload (0.5 N for approximately
7 min), onto which a higher level of intermittent dynamic
load (13.0 N) was superimposed in a series of 40
trapezoidal-shaped pulses (0.025-s loading, 0.050-s hold at
13.5 N, and 0.025-s unloading) with a 10-s rest interval
between each pulse. Although a peak load of 12.0 N has
been shown previously to induce significant osteogenic
responses [18], a higher peak load (13.5 N) was selected
in order to assess the effect of NS-398 on both lamellar
and woven bone because a previous study had described
different effects of NS-398 on lamellar and woven bone
formation induced by a single loading episode [9]. It
has been previously shown that this higher peak load
results in loading-related woven bone formation in the
cortical region of the proximal to middle tibiae and
loading-related lamellar bone formation in the cortical
region of the middle fibulae as well as in the trabecular
region (secondary spongiosa) of the proximal tibiae
[16]. Strain gauges attached to the proximal lateral tibial
shaft of similar 19-week-old female C57BL/6 mice ex vivo
showed that a peak load of 13.5 N engendered a peak strain of
approximately 1,800 με [19].
High-resolution micro-computed tomography analysis
Because mouse bone is small and the present axial loading-
related osteogenesis is site specific, high-resolution micro-
computed tomography (μCT; SkyScan 1172; SkyScan, Kon-
tich, Belgium) with a voxel size of 5 μm was used to quantify
three-dimensional bone architecture at precisely comparable
sites of the loaded and contralateral control tibiae/fibulae as
reported previously [15, 16, 18, 19]. Trabecular bone volume/
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tissue volume (BV/TV), trabecular number and trabecular
thickness were measured in the secondary spongiosa of the
proximal tibiae (0.05–1.00 mm distal to the growth plate).
Cortical bone volume, periosteally enclosed volume, medul-
lary volume and polar moment of inertia, a parameter of
structural bone strength, were determined in 0.5-mm-long
sections at four sites [25% (proximal), 37% (proximal/mid-
dle), 50% (middle) and 75% (distal) of bone length from its
proximal end] in the tibiae and at the 50% (middle) site in the
fibulae.
Statistical analysis
All data are shown as the means and SEM. Statistical analysis
was performed by one-way or two-way ANOVA using SPSS
(version 17.0; SPSS Inc., Chicago, USA). P<0.05 was con-
sidered statistically significant.
Results
Effects of NS-398 on body weight and bone length
There was no difference in body weight of mice treated with
vehicle (day 1: 22.4±0.4 g, day 15: 22.3±0.3 g) or NS-398
(day 1: 23.0±0.7 g, day 15: 22.6±0.6 g). Bone length was
similar in vehicle and NS-398-treated groups in the left control
(17.8±0.1 and 17.9±0.1 mm, respectively) and right loaded
(17.9±0.1 and 17.9±0.1 mm, respectively) tibiae and the left
control (9.6±0.1 and 9.8±0.1 mm, respectively) and right
loaded (9.7±0.1 and 9.7±0.1 mm, respectively) fibulae.
Effects of NS-398 on trabecular and cortical bone
In trabecular bone of the proximal tibiae, NS-398 was associ-
ated with significant decreases in BV/TV and trabecular
Table 1 Trabecular and cortical μCT parameters in the left control and right loaded tibiae/fibulae in 21-week-old female C57BL/6 mice treated
with vehicle or NS-398 (5 mg/kg/day, 5 days/week) for 2 weeks
Vehicle +
control
Vehicle +
loading
NS-398 +
control
NS-398 +
loading
NS-398 P value
loading
Interaction
Trabecular bone of the proximal tibia
Bone volume/tissue volume (%) 17.5±0.5 24.7±0.9 16.4±0.3 22.4±0.4 0.008 <0.001 0.355
Trabecular number (mm−1) 3.30±0.08 3.71±0.10 3.10±0.05 3.44±0.05 0.004 <0.001 0.644
Trabecular thickness (μm) 52.9±0.6 66.5±0.9 52.7±1.1 65.2±1.0 0.441 <0.001 0.559
Cortical bone of the tibia
Proximal site
Bone volume (mm3) 0.403±0.006 0.543±0.010 0.411±0.008 0.544±0.011 0.642 <0.001 0.682
Periosteally enclosed volume (mm3) 0.713±0.011 0.840±0.012 0.741±0.012 0.847±0.014 0.170 <0.001 0.397
Medullary volume (mm3) 0.309±0.007 0.297±0.006 0.330±0.007 0.303±0.008 0.079 0.013 0.347
Proximal/middle site
Bone volume (mm3) 0.378±0.003 0.518±0.010 0.386±0.007 0.515±0.010 0.761 <0.001 0.480
Periosteally enclosed volume (mm3) 0.614±0.008 0.749±0.008 0.626±0.011 0.746±0.010 0.638 <0.001 0.448
Medullary volume (mm3) 0.236±0.007 0.230±0.002 0.240±0.006 0.231±0.005 0.692 0.144 0.751
Middle site
Bone volume (mm3) 0.297±0.004 0.381±0.004 0.309±0.006 0.386±0.010 0.208 <0.001 0.554
Periosteally enclosed volume (mm3) 0.483±0.007 0.553±0.006 0.495±0.010 0.558±0.011 0.319 <0.001 0.706
Medullary volume (mm3) 0.186±0.004 0.171±0.004 0.186±0.005 0.172±0.004 0.939 0.002 0.885
Distal site
Bone volume (mm3) 0.274±0.004 0.272±0.004 0.280±0.008 0.274±0.006 0.474 0.475 0.747
Periosteally enclosed volume (mm3) 0.371±0.005 0.373±0.005 0.382±0.009 0.381±0.010 0.211 0.952 0.862
Medullary volume (mm3) 0.097±0.002 0.102±0.003 0.102±0.002 0.107±0.004 0.074 0.102 0.825
Cortical bone of the fibula
Middle site
Bone volume (mm3) 0.0523±0.0009 0.0664±0.0021 0.0511±0.0006 0.0657±0.0019 0.516 <0.001 0.878
Periosteally enclosed volume (mm3) 0.0587±0.0014 0.0719±0.0020 0.0562±0.0005 0.0704±0.0015 0.188 <0.001 0.712
Medullary volume (mm3) 0.0065±0.0006 0.0054±0.0003 0.0051±0.0003 0.0048±0.0006 0.054 0.160 0.527
Values are presented as the means±SEM (n08 in each group). Two-way ANOVAwas used to compare groups. A P value of < 0.05 was considered
statistically significant (in bold)
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number, but not trabecular thickness, as shown in Table 1. In
contrast, no effect of NS-398 was detected in cortical bone of
the tibiae/fibulae.
Effects of NS-398 on trabecular and cortical bone’s response
to mechanical loading
In trabecular bone, mechanical loading significantly in-
creased BV/TV, trabecular thickness and trabecular number
(Table 1). Loading-related woven bone formation was not
seen in the secondary spongiosa (Fig. 1a), as confirmed
previously in the fluorochrome-labelled sections [16]. In
cortical bone, the effects of mechanical loading were site
specific; a loading-related increase in bone volume was
obtained in the proximal and middle tibiae and middle
fibulae, but not in the distal tibiae (Table 1). Consistent with
a previous finding [16], in the proximal to middle tibiae,
there was loading-related apparent woven bone formation
while at the middle fibulae such a woven bone response was
not observed (Fig. 1a). The loading-related increases in
cortical bone volume and polar moment of inertia (Fig. 1b)
were associated primarily with increased periosteally
enclosed volume. No effect of NS-398 was observed on
any of the loading responses at any site.
Discussion
The present experimental design enabled evaluation of the
effects of selective pharmacological inhibition of COX-2 by
daily NS-398 injection on changes in three-dimensional
bone architecture in trabecular as well as cortical bone
induced by repeated episodes of mechanical loading. In
control bones which received no more than normal functional
Fig. 1 a Representative transverse μCT images of the left control and
right loaded trabecular (0.5 mm distal to the growth plate) and cortical
(37% site of the bone’s longitudinal length from its proximal end) bone
in the tibiae and cortical bone (50% site of the bone’s longitudinal
length from its proximal end) in the fibulae in 21-week-old female
C57BL/6 mice treated with vehicle or NS-398 (5 mg/kg/day, 5 days/
week) for 2 weeks. Note that woven bone formation is observed in
cortical bone of the right loaded proximal/middle tibia, but not of the
right loaded middle fibula. b Mechanical loading-related changes
[(right loaded − left control)/left control] in polar moment of inertia,
a parameter of structural bone strength, in 21-week-old female C57BL/
6 mice treated with vehicle or NS-398 (5 mg/kg/day, 5 days/week) for
2 weeks. Values are presented as the means and SEM (n08 in each
group). No significant difference was detected between vehicle and
NS-398 groups by one-way ANOVA
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mechanical loading, NS-398 slightly but significantly de-
creased trabecular BV/TVof the proximal tibiae. This would
be compatible with a small reduction in bone mass of COX-2
deficient mice [11]. In bones that had been artificially loaded,
COX-2 inhibition had no discernible effect on the loading-
related lamellar or woven bone response in either trabecular or
cortical compartments. As a result, NS-398 showed no influ-
ence on the loading-related increase in polar moment of inertia,
a parameter of structural bone strength. Although theremay be a
potential small inhibitory effect of NS-398 on bone’s response
to mechanical loading that could be detected only by histo-
morphometry, such an effect would not alter the conclusion of
the present study.
The present data are consistent with the evidence from
female mice lacking COX-2 [11], showing that bone adap-
tation to two consecutive days of mechanical loading does
not require a functional COX-2 gene. The authors [11]
suggested a compensatory effect of COX-1 in vivo, though
this enzyme does not appear to be important for bone cells’
response to a single period of fluid flow in vitro [20]. If such
compensation exists, it does not seem to be immediately
available since in female rats a single injection of NS-398
reduces the cortical response to a single period of mechan-
ical loading [9, 10]. The data we present here suggest that
compensation for the pharmacological inhibition of COX-2
function does exist and can occur sufficiently swiftly to
ensure that adaptive (re)modelling of trabecular and cortical
bone to artificial mechanical loading over a 2-week period is
not impaired.
The relevance of the present experiment in female
mice to the human condition must take into account a
number of differences in the two situations. Importantly,
however, our experimental data of three-dimensional
bone architecture analysed by high-resolution μCT are
compatible with clinical evidence that women taking
COX-2 selective inhibitors such as celecoxib and rofe-
coxib do not have lower hip areal BMD [13]. In con-
trast to women, the use of the COX-2 selective inhibitors is
associated with lower hip areal BMD in men [13]. It remains
to be elucidated whether there are sex differences in the effects
of COX-2 inhibition on bone’s response to mechanical
loading.
In conclusion, our present data demonstrate that in female
mice pharmacological inhibition of COX-2 using daily NS-
398 injection does not affect trabecular or cortical bone gain
engendered by repeated periods of mechanical loading over
a 2-week period. Should this experimental finding be trans-
lated into the clinical situation, it would suggest that in
women long-term use of a COX-2 selective inhibitor does
not impair the adaptive response of either trabecular or
cortical bone to habitual mechanical loading and thus is
not expected to contribute to bone loss by interference with
this mechanism.
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